Mallinckrodt Public Limited Company provided earnings guidance for the fiscal year 2016. The company expected adjusted diluted earnings per share to be in the range of $7.70 to $8.20 for fiscal 2016. The company expected 2016 net sales to increase at least 10% on an operational basis, excluding fluctuations in foreign currency exchange rates.

Net sales for the company's Specialty Brands segment are expected to increase at least 30%. Total sales for the company's Specialty Generics segment are expected to decrease 15% to 20% and sales for the company's Global Medical Imaging segment are expected to decrease 5% to 10%.